BB Healthcare's Paul Major: Biotech trust sector marred by 'dubious' company influx

Recent roundtable

Elliot Gulliver-Needham
clock • 3 min read

All of the investment trusts in the AIC biotechnology and healthcare sector are on discounts and just two have had positive 12-month performance figures, according to Morningstar.

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Investment Trusts

Trustpilot